Abstract
Background The speed of vaccine development has been a singular achievement during the SARS-CoV-2 pandemic. However, anti-vaccination movements and disinformation efforts have resulted in suboptimal uptake of available vaccines. Vaccine opponents often frame their opposition in terms of the rights of the unvaccinated. Our objective was to explore the impact of mixing of vaccinated and unvaccinated populations on risk among vaccinated individuals.
Methods We constructed a simple Susceptible-Infectious-Recovered (SIR) compartmental model of a respiratory infectious disease with two connected sub-populations: vaccinated individuals and unvaccinated individuals. We simulated a spectrum of patterns of mixing between vaccinated and unvaccinated groups that from random mixing to like-with-like mixing (complete assortativity). We evaluated the dynamics of an epidemic within each subgroup, and in the population as a whole, and also evaluated the contact-frequency-adjusted contribution of unvaccinated individuals to risk among the vaccinated.
Results As expected, the relative risk of infection was markedly higher among unvaccinated individuals than among vaccinated individuals. However, the contact-adjusted contribution of unvaccinated individuals to infection risk during the epidemic was disproportionate, with unvaccinated individuals contributing to infection risk among the vaccinated at a rate up to 6.4 times higher than would have been expected based on contact numbers alone in the base case. As assortativity increased, the final attack rate decreased among vaccinated individuals, but the contact-adjusted contribution to risk among vaccinated individuals derived from contact with unvaccinated individuals increased.
Interpretation While risk associated with avoiding vaccination during a virulent pandemic accrues chiefly to the unvaccinated, the choices of these individuals are likely to impact the health and safety of vaccinated individuals in a manner disproportionate to the fraction of unvaccinated individuals in the population.
Competing Interest Statement
Dr. Fisman has served on advisory boards related to influenza and SARS-CoV-2 vaccines for Seqirus, Pfizer, Astrazeneca and Sanofi-Pasteur Vaccines, and has served as a legal expert on issues related to COVID-19 epidemiology for the Elementary Teachers Federation of Ontario and the Registered Nurses Association of Ontario.
Funding Statement
Canadian Institutes for Health Research
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding statement: The research was supported by a grant to DNF from the Canadians Institutes for Health Research (2019 COVID-19 rapid researching funding OV4-170360).
Declaration of competing interests: DNF has served on advisory boards related to influenza and SARS-CoV-2 vaccines for Seqirus, Pfizer, Astrazeneca and Sanofi-Pasteur Vaccines, and has served as a legal expert on issues related to COVID-19 epidemiology for the Elementary Teachers Federation of Ontario and the Registered Nurses Association of Ontario. ART was employed by the Public Health Agency of Canada when the research was conducted. The work does not represent the views of the Public Health Agency of Canada.
Data Availability
Data and model are available at Figshare via DOI 10.6084/m9.figshare.15189576
https://figshare.com/articles/dataset/Simple_2-Patch_Vaccine_Model/15189576
